Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Spratt

Showing results (421-430 of 498) with videos related to

Pageof 50
Sort By:
European Urology|November 14, 2019
Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized TrialsAmar U Kishan, Fang-I Chu, Christopher R King, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2026
Correlation of Biochemical Recurrence with Adverse Late Toxic Events Following Prostate Radiotherapy (COBALT Study): An Individual Patient Data Meta-Analysis of 7 Randomized TrialsJohn Nikitas, Parsa Jamshidian, Alison C Tree, et al.
JCO Clinical Cancer Informatics|May 9, 2025
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III TrialsMack Roach, Jingbin Zhang, Osama Mohamad, et al.
Acta Neuropathologica Communications|July 28, 2018
Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG RegistryHunter C Gits, Maia Anderson, Stefanie Stallard, et al.
Prostate Cancer and Prostatic Diseases|December 9, 2025
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancerUdit Singhal, Ralph Jiang, James A Proudfoot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2020
Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-AnalysisDaniel E Spratt, Shawn Malone, Soumyajit Roy, et al.
Cancer|January 5, 2022
TrueNTH Sexual Recovery Intervention for couples coping with prostate cancer: Randomized controlled trial resultsDaniela Wittmann, Akanksha Mehta, Sharon L Bober, et al.
JAMA Network Open|October 24, 2024
Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of LifeSagar A Patel, Dattatraya Patil, Joseph Smith, et al.
Prostate Cancer and Prostatic Diseases|April 2, 2020
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifierJeffrey J Tosoian, Samuel R Birer, R Jeffrey Karnes, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2020
NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate CancerWilliam A Hall, Eric Paulson, Brian J Davis, et al.
Pageof 50

Showing results (421-430 of 498) with videos related to

Sort By:
Pageof 50
European Urology|November 14, 2019
Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized TrialsAmar U Kishan, Fang-I Chu, Christopher R King, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2026
Correlation of Biochemical Recurrence with Adverse Late Toxic Events Following Prostate Radiotherapy (COBALT Study): An Individual Patient Data Meta-Analysis of 7 Randomized TrialsJohn Nikitas, Parsa Jamshidian, Alison C Tree, et al.
JCO Clinical Cancer Informatics|May 9, 2025
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III TrialsMack Roach, Jingbin Zhang, Osama Mohamad, et al.
Acta Neuropathologica Communications|July 28, 2018
Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG RegistryHunter C Gits, Maia Anderson, Stefanie Stallard, et al.
Prostate Cancer and Prostatic Diseases|December 9, 2025
Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancerUdit Singhal, Ralph Jiang, James A Proudfoot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2020
Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-AnalysisDaniel E Spratt, Shawn Malone, Soumyajit Roy, et al.
Cancer|January 5, 2022
TrueNTH Sexual Recovery Intervention for couples coping with prostate cancer: Randomized controlled trial resultsDaniela Wittmann, Akanksha Mehta, Sharon L Bober, et al.
JAMA Network Open|October 24, 2024
Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of LifeSagar A Patel, Dattatraya Patil, Joseph Smith, et al.
Prostate Cancer and Prostatic Diseases|April 2, 2020
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifierJeffrey J Tosoian, Samuel R Birer, R Jeffrey Karnes, et al.
International Journal of Radiation Oncology, Biology, Physics|August 31, 2020
NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate CancerWilliam A Hall, Eric Paulson, Brian J Davis, et al.
Pageof 50